APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Weight Loss and Obesity Management

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Weight Loss and Obesity Management Market Analysis and Forecast 2026-2032

Report ID 174047380220 December 2025195 pages

Choose your research edition.

Industry ResearchWeight Loss and Obesity Management Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Weight Loss and Obesity Management Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Weight Loss and Obesity Management Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Weight Loss and Obesity Management Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Weight Loss and Obesity Management Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Weight Loss and Obesity Management market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Weight Loss and Obesity Management is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Weight Loss and Obesity Management is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Weight Loss and Obesity Management is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Weight Loss and Obesity Management is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Weight Loss and Obesity Management include Eisai, Johnson & Johnson, Novo Nordisk, Medtronic, Roche, GlaxoSmithKline, Vivus Inc, ReShape Lifesciences and Obalon Therapeutics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Weight Loss and Obesity Management, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Weight Loss and Obesity Management, also provides the revenue of main regions and countries. Of the upcoming market potential for Weight Loss and Obesity Management, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Weight Loss and Obesity Management revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Weight Loss and Obesity Management market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Weight Loss and Obesity Management revenue, projected growth trends, production technology, application and end-user industry.

Weight Loss and Obesity Management Segment by Company

Eisai

Johnson & Johnson

Novo Nordisk

Medtronic

Roche

GlaxoSmithKline

Vivus Inc

ReShape Lifesciences

Obalon Therapeutics

Nalpropion Pharmaceuticals

Beijing Noble Laser Technology

Allurion Technologies

Allergan

Weight Loss and Obesity Management Segment by Type

Weight Loss and Obesity Management Devices

Weight Loss and Obesity Management Drugs

Weight Loss and Obesity Management Segment by Application

Men

Women

Weight Loss and Obesity Management Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Weight Loss and Obesity Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Weight Loss and Obesity Management and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Weight Loss and Obesity Management.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Weight Loss and Obesity Management in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Weight Loss and Obesity Management company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Weight Loss and Obesity Management revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Weight Loss and Obesity Management Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Weight Loss and Obesity Management Devices Major Player Table 3. Weight Loss and Obesity Management Drugs Major Player Table 4. Global Weight Loss and Obesity Management Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Men Major Player Table 6. Women Major Player Table 7. Weight Loss and Obesity Management Industry Trends Table 8. Weight Loss and Obesity Management Industry Drivers Table 9. Weight Loss and Obesity Management Industry Opportunities and Challenges Table 10. Weight Loss and Obesity Management Industry Restraints Table 11. Global Weight Loss and Obesity Management Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Weight Loss and Obesity Management Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Weight Loss and Obesity Management Market Share by Region (2021-2026) Table 14. Global Weight Loss and Obesity Management Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Weight Loss and Obesity Management Market Share by Region (2027-2032) Table 16. Global Weight Loss and Obesity Management Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Weight Loss and Obesity Management Revenue Market Share by Players (2021-2026) Table 18. Global Weight Loss and Obesity Management Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Weight Loss and Obesity Management Key Players Headquarters & Area Served Table 20. Global Weight Loss and Obesity Management Players, Product Type & Application Table 21. Global Weight Loss and Obesity Management Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Weight Loss and Obesity Management by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Weight Loss and Obesity Management Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Weight Loss and Obesity Management Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Weight Loss and Obesity Management Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Weight Loss and Obesity Management Revenue Market Share by Type (2021-2026) Table 28. Global Weight Loss and Obesity Management Revenue Market Share by Type (2027-2032) Table 29. Global Weight Loss and Obesity Management Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Weight Loss and Obesity Management Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Weight Loss and Obesity Management Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Weight Loss and Obesity Management Revenue Market Share by Application (2021-2026) Table 33. Global Weight Loss and Obesity Management Revenue Market Share by Application (2027-2032) Table 34. Eisai Company Information Table 35. Eisai Business Overview Table 36. Eisai Weight Loss and Obesity Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Eisai Weight Loss and Obesity Management Product Portfolio Table 38. Eisai Recent Development Table 39. Johnson & Johnson Company Information Table 40. Johnson & Johnson Business Overview Table 41. Johnson & Johnson Weight Loss and Obesity Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Johnson & Johnson Weight Loss and Obesity Management Product Portfolio Table 43. Johnson & Johnson Recent Development Table 44. Novo Nordisk Company Information Table 45. Novo Nordisk Business Overview Table 46. Novo Nordisk Weight Loss and Obesity Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Novo Nordisk Weight Loss and Obesity Management Product Portfolio Table 48. Novo Nordisk Recent Development Table 49. Medtronic Company Information Table 50. Medtronic Business Overview Table 51. Medtronic Weight Loss and Obesity Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Medtronic Weight Loss and Obesity Management Product Portfolio Table 53. Medtronic Recent Development Table 54. Roche Company Information Table 55. Roche Business Overview Table 56. Roche Weight Loss and Obesity Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Roche Weight Loss and Obesity Management Product Portfolio Table 58. Roche Recent Development Table 59. GlaxoSmithKline Company Information Table 60. GlaxoSmithKline Business Overview Table 61. GlaxoSmithKline Weight Loss and Obesity Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. GlaxoSmithKline Weight Loss and Obesity Management Product Portfolio Table 63. GlaxoSmithKline Recent Development Table 64. Vivus Inc Company Information Table 65. Vivus Inc Business Overview Table 66. Vivus Inc Weight Loss and Obesity Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Vivus Inc Weight Loss and Obesity Management Product Portfolio Table 68. Vivus Inc Recent Development Table 69. ReShape Lifesciences Company Information Table 70. ReShape Lifesciences Business Overview Table 71. ReShape Lifesciences Weight Loss and Obesity Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. ReShape Lifesciences Weight Loss and Obesity Management Product Portfolio Table 73. ReShape Lifesciences Recent Development Table 74. Obalon Therapeutics Company Information Table 75. Obalon Therapeutics Business Overview Table 76. Obalon Therapeutics Weight Loss and Obesity Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Obalon Therapeutics Weight Loss and Obesity Management Product Portfolio Table 78. Obalon Therapeutics Recent Development Table 79. Nalpropion Pharmaceuticals Company Information Table 80. Nalpropion Pharmaceuticals Business Overview Table 81. Nalpropion Pharmaceuticals Weight Loss and Obesity Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Nalpropion Pharmaceuticals Weight Loss and Obesity Management Product Portfolio Table 83. Nalpropion Pharmaceuticals Recent Development Table 84. Beijing Noble Laser Technology Company Information Table 85. Beijing Noble Laser Technology Business Overview Table 86. Beijing Noble Laser Technology Weight Loss and Obesity Management Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Beijing Noble Laser Technology Weight Loss and Obesity Management Product Portfolio Table 88. Beijing Noble Laser Technology Recent Development Table 89. Allurion Technologies Company Information Table 90. Allurion Technologies Business Overview Table 91. Allurion Technologies Weight Loss and Obesity Management Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Allurion Technologies Weight Loss and Obesity Management Product Portfolio Table 93. Allurion Technologies Recent Development Table 94. Allergan Company Information Table 95. Allergan Business Overview Table 96. Allergan Weight Loss and Obesity Management Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Allergan Weight Loss and Obesity Management Product Portfolio Table 98. Allergan Recent Development Table 99. North America Weight Loss and Obesity Management Revenue by Type (2021-2026) & (US$ Million) Table 100. North America Weight Loss and Obesity Management Revenue by Type (2027-2032) & (US$ Million) Table 101. North America Weight Loss and Obesity Management Revenue by Application (2021-2026) & (US$ Million) Table 102. North America Weight Loss and Obesity Management Revenue by Application (2027-2032) & (US$ Million) Table 103. North America Weight Loss and Obesity Management Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. North America Weight Loss and Obesity Management Revenue by Country (2021-2026) & (US$ Million) Table 105. North America Weight Loss and Obesity Management Revenue by Country (US$ Million) & (2027-2032) Table 106. Europe Weight Loss and Obesity Management Revenue by Type (2021-2026) & (US$ Million) Table 107. Europe Weight Loss and Obesity Management Revenue by Type (2027-2032) & (US$ Million) Table 108. Europe Weight Loss and Obesity Management Revenue by Application (2021-2026) & (US$ Million) Table 109. Europe Weight Loss and Obesity Management Revenue by Application (2027-2032) & (US$ Million) Table 110. Europe Weight Loss and Obesity Management Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. Europe Weight Loss and Obesity Management Revenue by Country (2021-2026) & (US$ Million) Table 112. Europe Weight Loss and Obesity Management Revenue by Country (US$ Million) & (2027-2032) Table 113. China Weight Loss and Obesity Management Revenue by Type (2021-2026) & (US$ Million) Table 114. China Weight Loss and Obesity Management Revenue by Type (2027-2032) & (US$ Million) Table 115. China Weight Loss and Obesity Management Revenue by Application (2021-2026) & (US$ Million) Table 116. China Weight Loss and Obesity Management Revenue by Application (2027-2032) & (US$ Million) Table 117. Asia Weight Loss and Obesity Management Revenue by Type (2021-2026) & (US$ Million) Table 118. Asia Weight Loss and Obesity Management Revenue by Type (2027-2032) & (US$ Million) Table 119. Asia Weight Loss and Obesity Management Revenue by Application (2021-2026) & (US$ Million) Table 120. Asia Weight Loss and Obesity Management Revenue by Application (2027-2032) & (US$ Million) Table 121. Asia Weight Loss and Obesity Management Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Asia Weight Loss and Obesity Management Revenue by Region (US$ Million) & (2021-2026) Table 123. Asia Weight Loss and Obesity Management Revenue by Region (US$ Million) & (2027-2032) Table 124. SAMEA Weight Loss and Obesity Management Revenue by Type (2021-2026) & (US$ Million) Table 125. SAMEA Weight Loss and Obesity Management Revenue by Type (2027-2032) & (US$ Million) Table 126. SAMEA Weight Loss and Obesity Management Revenue by Application (2021-2026) & (US$ Million) Table 127. SAMEA Weight Loss and Obesity Management Revenue by Application (2027-2032) & (US$ Million) Table 128. SAMEA Weight Loss and Obesity Management Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. SAMEA Weight Loss and Obesity Management Revenue by Country (2021-2026) & (US$ Million) Table 130. SAMEA Weight Loss and Obesity Management Revenue by Country (US$ Million) & (2027-2032) Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Weight Loss and Obesity Management Image Figure 2. Global Weight Loss and Obesity Management Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Weight Loss and Obesity Management Market Size Share 2021 VS 2025 VS 2032 Figure 4. Weight Loss and Obesity Management Devices Image Figure 5. Weight Loss and Obesity Management Drugs Image Figure 6. Global Weight Loss and Obesity Management Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Weight Loss and Obesity Management Market Size Share 2021 VS 2025 VS 2032 Figure 8. Men Image Figure 9. Women Image Figure 10. Global Weight Loss and Obesity Management Market Size (US$ Million) & (2021-2032) Figure 11. Global Weight Loss and Obesity Management Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Weight Loss and Obesity Management Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Weight Loss and Obesity Management Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Weight Loss and Obesity Management Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Weight Loss and Obesity Management Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Weight Loss and Obesity Management Revenue Market Share by Type (2021-2032) Figure 18. Global Weight Loss and Obesity Management Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Weight Loss and Obesity Management Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Weight Loss and Obesity Management Revenue Market Share by Application (2021-2032) Figure 21. North America Weight Loss and Obesity Management Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Weight Loss and Obesity Management Revenue Share by Type (2021-2032) Figure 23. North America Weight Loss and Obesity Management Revenue Share by Application (2021-2032) Figure 24. North America Weight Loss and Obesity Management Revenue Share by Country (2021-2032) Figure 25. United States Weight Loss and Obesity Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Weight Loss and Obesity Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Weight Loss and Obesity Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Weight Loss and Obesity Management Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Weight Loss and Obesity Management Revenue Share by Type (2021-2032) Figure 30. Europe Weight Loss and Obesity Management Revenue Share by Application (2021-2032) Figure 31. Europe Weight Loss and Obesity Management Revenue Share by Country (2021-2032) Figure 32. Germany Weight Loss and Obesity Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Weight Loss and Obesity Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Weight Loss and Obesity Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Weight Loss and Obesity Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Weight Loss and Obesity Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Weight Loss and Obesity Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Weight Loss and Obesity Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Weight Loss and Obesity Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Weight Loss and Obesity Management Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Weight Loss and Obesity Management Revenue Share by Type (2021-2032) Figure 42. China Weight Loss and Obesity Management Revenue Share by Application (2021-2032) Figure 43. Asia Weight Loss and Obesity Management Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Weight Loss and Obesity Management Revenue Share by Type (2021-2032) Figure 45. Asia Weight Loss and Obesity Management Revenue Share by Application (2021-2032) Figure 46. Asia Weight Loss and Obesity Management Revenue Share by Region (2021-2032) Figure 47. Japan Weight Loss and Obesity Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Weight Loss and Obesity Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Weight Loss and Obesity Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Weight Loss and Obesity Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Weight Loss and Obesity Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Weight Loss and Obesity Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Weight Loss and Obesity Management Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Weight Loss and Obesity Management Revenue Share by Type (2021-2032) Figure 55. SAMEA Weight Loss and Obesity Management Revenue Share by Application (2021-2032) Figure 56. SAMEA Weight Loss and Obesity Management Revenue Share by Country (2021-2032) Figure 57. Brazil Weight Loss and Obesity Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Weight Loss and Obesity Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Weight Loss and Obesity Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Weight Loss and Obesity Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Weight Loss and Obesity Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Weight Loss and Obesity Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Weight Loss and Obesity Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Weight Loss and Obesity Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Weight Loss and Obesity Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Weight Loss and Obesity Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Weight Loss and Obesity Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Weight Loss and Obesity Management Devices
  • Weight Loss and Obesity Management Drugs
Applications
  • Men
  • Women
Companies covered
  • Eisai
  • Johnson & Johnson
  • Novo Nordisk
  • Medtronic
  • Roche
  • GlaxoSmithKline
  • Vivus Inc
  • ReShape Lifesciences
  • Obalon Therapeutics
  • Nalpropion Pharmaceuticals
  • Beijing Noble Laser Technology
  • Allurion Technologies
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Weight Loss and Obesity Management Market by Type
  3. 1.2.1 Global Weight Loss and Obesity Management Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Weight Loss and Obesity Management Devices
  5. 1.2.3 Weight Loss and Obesity Management Drugs
  6. 1.3 Weight Loss and Obesity Management Market by Application
  7. 1.3.1 Global Weight Loss and Obesity Management Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Men
  9. 1.3.3 Women
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Weight Loss and Obesity Management Market Dynamics
  1. 2.1 Weight Loss and Obesity Management Industry Trends
  2. 2.2 Weight Loss and Obesity Management Industry Drivers
  3. 2.3 Weight Loss and Obesity Management Industry Opportunities and Challenges
  4. 2.4 Weight Loss and Obesity Management Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Weight Loss and Obesity Management Market Perspective (2021-2032)
  2. 3.2 Global Weight Loss and Obesity Management Growth Trends by Region
  3. 3.2.1 Global Weight Loss and Obesity Management Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Weight Loss and Obesity Management Market Size by Region (2021-2026)
  5. 3.2.3 Global Weight Loss and Obesity Management Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Weight Loss and Obesity Management Revenue by Players
  2. 4.1.1 Global Weight Loss and Obesity Management Revenue by Players (2021-2026)
  3. 4.1.2 Global Weight Loss and Obesity Management Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Weight Loss and Obesity Management Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Weight Loss and Obesity Management Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Weight Loss and Obesity Management Key Players Headquarters & Area Served
  7. 4.4 Global Weight Loss and Obesity Management Players, Product Type & Application
  8. 4.5 Global Weight Loss and Obesity Management Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Weight Loss and Obesity Management Market CR5 and HHI
  11. 4.6.3 2025 Weight Loss and Obesity Management Tier 1, Tier 2, and Tier 3
5 Weight Loss and Obesity Management Market Size by Type
  1. 5.1 Global Weight Loss and Obesity Management Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Weight Loss and Obesity Management Revenue by Type (2021-2032)
  3. 5.3 Global Weight Loss and Obesity Management Revenue Market Share by Type (2021-2032)
6 Weight Loss and Obesity Management Market Size by Application
  1. 6.1 Global Weight Loss and Obesity Management Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Weight Loss and Obesity Management Revenue by Application (2021-2032)
  3. 6.3 Global Weight Loss and Obesity Management Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Eisai
  2. 7.1.1 Eisai Company Information
  3. 7.1.2 Eisai Business Overview
  4. 7.1.3 Eisai Weight Loss and Obesity Management Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Eisai Weight Loss and Obesity Management Product Portfolio
  6. 7.1.5 Eisai Recent Developments
  7. 7.2 Johnson & Johnson
  8. 7.2.1 Johnson & Johnson Company Information
  9. 7.2.2 Johnson & Johnson Business Overview
  10. 7.2.3 Johnson & Johnson Weight Loss and Obesity Management Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Johnson & Johnson Weight Loss and Obesity Management Product Portfolio
  12. 7.2.5 Johnson & Johnson Recent Developments
  13. 7.3 Novo Nordisk
  14. 7.3.1 Novo Nordisk Company Information
  15. 7.3.2 Novo Nordisk Business Overview
  16. 7.3.3 Novo Nordisk Weight Loss and Obesity Management Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Novo Nordisk Weight Loss and Obesity Management Product Portfolio
  18. 7.3.5 Novo Nordisk Recent Developments
  19. 7.4 Medtronic
  20. 7.4.1 Medtronic Company Information
  21. 7.4.2 Medtronic Business Overview
  22. 7.4.3 Medtronic Weight Loss and Obesity Management Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Medtronic Weight Loss and Obesity Management Product Portfolio
  24. 7.4.5 Medtronic Recent Developments
  25. 7.5 Roche
  26. 7.5.1 Roche Company Information
  27. 7.5.2 Roche Business Overview
  28. 7.5.3 Roche Weight Loss and Obesity Management Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Roche Weight Loss and Obesity Management Product Portfolio
  30. 7.5.5 Roche Recent Developments
  31. 7.6 GlaxoSmithKline
  32. 7.6.1 GlaxoSmithKline Company Information
  33. 7.6.2 GlaxoSmithKline Business Overview
  34. 7.6.3 GlaxoSmithKline Weight Loss and Obesity Management Revenue and Gross Margin (2021-2026)
  35. 7.6.4 GlaxoSmithKline Weight Loss and Obesity Management Product Portfolio
  36. 7.6.5 GlaxoSmithKline Recent Developments
  37. 7.7 Vivus Inc
  38. 7.7.1 Vivus Inc Company Information
  39. 7.7.2 Vivus Inc Business Overview
  40. 7.7.3 Vivus Inc Weight Loss and Obesity Management Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Vivus Inc Weight Loss and Obesity Management Product Portfolio
  42. 7.7.5 Vivus Inc Recent Developments
  43. 7.8 ReShape Lifesciences
  44. 7.8.1 ReShape Lifesciences Company Information
  45. 7.8.2 ReShape Lifesciences Business Overview
  46. 7.8.3 ReShape Lifesciences Weight Loss and Obesity Management Revenue and Gross Margin (2021-2026)
  47. 7.8.4 ReShape Lifesciences Weight Loss and Obesity Management Product Portfolio
  48. 7.8.5 ReShape Lifesciences Recent Developments
  49. 7.9 Obalon Therapeutics
  50. 7.9.1 Obalon Therapeutics Company Information
  51. 7.9.2 Obalon Therapeutics Business Overview
  52. 7.9.3 Obalon Therapeutics Weight Loss and Obesity Management Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Obalon Therapeutics Weight Loss and Obesity Management Product Portfolio
  54. 7.9.5 Obalon Therapeutics Recent Developments
  55. 7.10 Nalpropion Pharmaceuticals
  56. 7.10.1 Nalpropion Pharmaceuticals Company Information
  57. 7.10.2 Nalpropion Pharmaceuticals Business Overview
  58. 7.10.3 Nalpropion Pharmaceuticals Weight Loss and Obesity Management Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Nalpropion Pharmaceuticals Weight Loss and Obesity Management Product Portfolio
  60. 7.10.5 Nalpropion Pharmaceuticals Recent Developments
  61. 7.11 Beijing Noble Laser Technology
  62. 7.11.1 Beijing Noble Laser Technology Company Information
  63. 7.11.2 Beijing Noble Laser Technology Business Overview
  64. 7.11.3 Beijing Noble Laser Technology Weight Loss and Obesity Management Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Beijing Noble Laser Technology Weight Loss and Obesity Management Product Portfolio
  66. 7.11.5 Beijing Noble Laser Technology Recent Developments
  67. 7.12 Allurion Technologies
  68. 7.12.1 Allurion Technologies Company Information
  69. 7.12.2 Allurion Technologies Business Overview
  70. 7.12.3 Allurion Technologies Weight Loss and Obesity Management Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Allurion Technologies Weight Loss and Obesity Management Product Portfolio
  72. 7.12.5 Allurion Technologies Recent Developments
  73. 7.13 Allergan
  74. 7.13.1 Allergan Company Information
  75. 7.13.2 Allergan Business Overview
  76. 7.13.3 Allergan Weight Loss and Obesity Management Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Allergan Weight Loss and Obesity Management Product Portfolio
  78. 7.13.5 Allergan Recent Developments
8 North America
  1. 8.1 North America Weight Loss and Obesity Management Revenue (2021-2032)
  2. 8.2 North America Weight Loss and Obesity Management Revenue by Type (2021-2032)
  3. 8.2.1 North America Weight Loss and Obesity Management Revenue by Type (2021-2026)
  4. 8.2.2 North America Weight Loss and Obesity Management Revenue by Type (2027-2032)
  5. 8.3 North America Weight Loss and Obesity Management Revenue Share by Type (2021-2032)
  6. 8.4 North America Weight Loss and Obesity Management Revenue by Application (2021-2032)
  7. 8.4.1 North America Weight Loss and Obesity Management Revenue by Application (2021-2026)
  8. 8.4.2 North America Weight Loss and Obesity Management Revenue by Application (2027-2032)
  9. 8.5 North America Weight Loss and Obesity Management Revenue Share by Application (2021-2032)
  10. 8.6 North America Weight Loss and Obesity Management Revenue by Country
  11. 8.6.1 North America Weight Loss and Obesity Management Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Weight Loss and Obesity Management Revenue by Country (2021-2026)
  13. 8.6.3 North America Weight Loss and Obesity Management Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Weight Loss and Obesity Management Revenue (2021-2032)
  2. 9.2 Europe Weight Loss and Obesity Management Revenue by Type (2021-2032)
  3. 9.2.1 Europe Weight Loss and Obesity Management Revenue by Type (2021-2026)
  4. 9.2.2 Europe Weight Loss and Obesity Management Revenue by Type (2027-2032)
  5. 9.3 Europe Weight Loss and Obesity Management Revenue Share by Type (2021-2032)
  6. 9.4 Europe Weight Loss and Obesity Management Revenue by Application (2021-2032)
  7. 9.4.1 Europe Weight Loss and Obesity Management Revenue by Application (2021-2026)
  8. 9.4.2 Europe Weight Loss and Obesity Management Revenue by Application (2027-2032)
  9. 9.5 Europe Weight Loss and Obesity Management Revenue Share by Application (2021-2032)
  10. 9.6 Europe Weight Loss and Obesity Management Revenue by Country
  11. 9.6.1 Europe Weight Loss and Obesity Management Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Weight Loss and Obesity Management Revenue by Country (2021-2026)
  13. 9.6.3 Europe Weight Loss and Obesity Management Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Weight Loss and Obesity Management Revenue (2021-2032)
  2. 10.2 China Weight Loss and Obesity Management Revenue by Type (2021-2032)
  3. 10.2.1 China Weight Loss and Obesity Management Revenue by Type (2021-2026)
  4. 10.2.2 China Weight Loss and Obesity Management Revenue by Type (2027-2032)
  5. 10.3 China Weight Loss and Obesity Management Revenue Share by Type (2021-2032)
  6. 10.4 China Weight Loss and Obesity Management Revenue by Application (2021-2032)
  7. 10.4.1 China Weight Loss and Obesity Management Revenue by Application (2021-2026)
  8. 10.4.2 China Weight Loss and Obesity Management Revenue by Application (2027-2032)
  9. 10.5 China Weight Loss and Obesity Management Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Weight Loss and Obesity Management Revenue (2021-2032)
  2. 11.2 Asia Weight Loss and Obesity Management Revenue by Type (2021-2032)
  3. 11.2.1 Asia Weight Loss and Obesity Management Revenue by Type (2021-2026)
  4. 11.2.2 Asia Weight Loss and Obesity Management Revenue by Type (2027-2032)
  5. 11.3 Asia Weight Loss and Obesity Management Revenue Share by Type (2021-2032)
  6. 11.4 Asia Weight Loss and Obesity Management Revenue by Application (2021-2032)
  7. 11.4.1 Asia Weight Loss and Obesity Management Revenue by Application (2021-2026)
  8. 11.4.2 Asia Weight Loss and Obesity Management Revenue by Application (2027-2032)
  9. 11.5 Asia Weight Loss and Obesity Management Revenue Share by Application (2021-2032)
  10. 11.6 Asia Weight Loss and Obesity Management Revenue by Country
  11. 11.6.1 Asia Weight Loss and Obesity Management Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Weight Loss and Obesity Management Revenue by Country (2021-2026)
  13. 11.6.3 Asia Weight Loss and Obesity Management Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Weight Loss and Obesity Management Revenue (2021-2032)
  2. 12.2 SAMEA Weight Loss and Obesity Management Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Weight Loss and Obesity Management Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Weight Loss and Obesity Management Revenue by Type (2027-2032)
  5. 12.3 SAMEA Weight Loss and Obesity Management Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Weight Loss and Obesity Management Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Weight Loss and Obesity Management Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Weight Loss and Obesity Management Revenue by Application (2027-2032)
  9. 12.5 SAMEA Weight Loss and Obesity Management Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Weight Loss and Obesity Management Revenue by Country
  11. 12.6.1 SAMEA Weight Loss and Obesity Management Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Weight Loss and Obesity Management Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Weight Loss and Obesity Management Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst